Archive:
Dec 3, 2021, 12:00 AM
CNYBAC Client Zetagen Therapeutics receives FDA Breakthrough Device Designation for ZetaMet
December
03,
2021
ZetaMet™ Receives Breakthrough Device Designation from U. S.
Read More »